Vaccarin
|
|
53452-16-7
|
CH5132799
|
|
1007207-67-1
|
GSK-3 inhibitor 1
|
|
603272-51-1
|
CC-115 hydrochloride
|
|
1300118-55-1
|
Buformin hydrochloride
|
|
1190-53-0
|
Metformin
|
|
657-24-9
|
Loureirin A
|
|
119425-89-7
|
CGK733
|
|
905973-89-9
|
Nepodin
|
|
3785-24-8
|
N-Deshydroxyethyl Dasatinib
|
|
910297-51-7
|
LY2090314
|
|
603288-22-8
|
CNX-1351
|
|
1276105-89-5
|
SAMS
|
|
125911-68-4
|
ARV-771
|
|
1949837-12-0
|
Amarogentin
|
|
21018-84-8
|
Sonolisib
|
|
502632-66-8
|
ASP4132
|
|
1640294-30-9
|
Dihydromyricetin
|
|
27200-12-0
|
PQR626
|
|
1927857-98-4
|
α-Linolenic acid
|
|
463-40-1
|
PF-04691502
|
|
1013101-36-4
|
GDC-0349
|
|
1207360-89-1
|
Ipatasertib dihydrochloride
|
|
1396257-94-5
|
Phenformin hydrochloride
|
|
834-28-6
|
PI4KIIIbeta-IN-9
|
|
1429624-84-9
|
dBET1
|
|
1799711-21-9
|
Copanlisib dihydrochloride
|
|
1402152-13-9
|
PROTAC BRD9 Degrader-1
|
|
2097971-01-0
|
7-Methoxyisoflavone
|
|
1621-56-3
|
Crebanine
|
|
25127-29-1
|
Glaucocalyxin A
|
|
79498-31-0
|
Duvelisib
|
|
1201438-56-3
|
XL388
|
|
1251156-08-7
|
KU 59403
|
|
845932-30-1
|
CC-223
|
|
1228013-30-6
|
BF738735
|
|
1436383-95-7
|
Quercetin dihydrate
|
|
6151-25-3
|
I-BET762 carboxylic acid
|
|
1300019-38-8
|
(S)-Ceralasertib
|
|
1352226-87-9
|
Cyclovirobuxine D
|
|
860-79-7
|
SAR502250
|
|
503860-57-9
|
3CAI
|
|
28755-03-5
|
Karanjin
|
|
521-88-0
|
Euscaphic acid
|
|
53155-25-2
|
KU-0063794
|
|
938440-64-3
|
SC66
|
|
871361-88-5
|
NVP-QAV-572
|
|
957209-68-6
|
VS-5584
|
|
1246560-33-7
|
(R)-PS210
|
|
1410101-89-1
|
Uprosertib
|
|
1047634-65-0
|
Tenalisib
|
|
1639417-53-0
|
Marein
|
|
535-96-6
|
3α-Hydroxymogrol
|
|
1343402-73-2
|
Palomid 529
|
|
914913-88-5
|
Alpelisib
|
|
1217486-61-7
|
GSK2636771
|
|
1372540-25-4
|
mTOR inhibitor-3
|
|
1207358-59-5
|
HS-173
|
|
1276110-06-5
|
OTSSP167 hydrochloride
|
|
1431698-10-0
|
ZLN024 hydrochloride
|
|
1883548-91-1
|
Duvelisib (R enantiomer)
|
|
1261590-48-0
|
PROTAC CDK9 Degrader-1
|
|
2118356-96-8
|
Kahweol
|
|
6894-43-5
|
FPA-124
|
|
902779-59-3
|
Akt1 and Akt2-IN-1
|
|
893422-47-4
|
PI4KIII beta inhibitor 3
|
|
1245319-54-3
|
GSK2334470
|
|
1227911-45-6
|
Heterophyllin B
|
|
145459-19-4
|
Taselisib
|
|
1282512-48-4
|
Voxtalisib
|
|
934493-76-2
|
Nemiralisib
|
|
1254036-71-9
|
PROTAC BET Degrader-1
|
|
2093386-22-0
|
WYE-687 dihydrochloride
|
|
1702364-87-1
|
Sophocarpine monohydrate
|
|
145572-44-7
|
Buparlisib Hydrochloride
|
|
1312445-63-8
|
CZC24832
|
|
1159824-67-5
|
Pilaralisib
|
|
934526-89-3
|
BEBT-908
|
|
1235449-52-1
|
ATR inhibitor 2
|
|
1613191-99-3
|
TMBIM6 antagonist-1
|
|
123134-61-2
|
Pictilisib dimethanesulfonate
|
|
957054-33-0
|
MP7
|
|
1001409-50-2
|
Hederacolchiside A1
|
|
106577-39-3
|
KP-23172
|
|
1374996-60-7
|
SC79
|
|
305834-79-1
|
VX-984
|
|
1476074-39-1
|
K-80003
|
|
1292821-90-9
|
Seletalisib
|
|
1362850-20-1
|
MT 63-78
|
|
1179347-65-9
|
BETd-260
|
|
2093388-62-4
|
NU 7026
|
|
154447-35-5
|
BIO-acetoxime
|
|
667463-85-6
|
Crosstide
|
|
171783-05-4
|
Dactolisib Tosylate
|
|
1028385-32-1
|
CAL-130 Hydrochloride
|
|
1431697-78-7
|
PF-4989216
|
|
1276553-09-3
|
BX517
|
|
850717-64-5
|
SAR-260301
|
|
1260612-13-2
|
MHY1485
|
|
326914-06-1
|
(+)-Usnic acid
|
|
7562-61-0
|